Logo

AKAN

Akanda Corp.

AKAN

Akanda Corp. NASDAQ
$1.03 -3.74% (-0.04)

Market Cap $2.34 M
52w High $9.29
52w Low $0.88
Dividend Yield 0%
P/E 0.03
Volume 190.38K
Outstanding Shares 2.28M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2024 $359.658K $2.377M $-1.413M -392.912% $-1.09 $-990.779K
Q2-2024 $477.006K $2.214M $-2.683M -562.444% $-2.84 $-2.036M
Q4-2023 $762.608K $3.406M $-26.397M -3.461K% $-228.2 $-1.952M
Q2-2023 $1.397M $3.164M $-5.878M -420.617% $-58.35 $-3.503M
Q4-2022 $2.547M $7.587M $-9.064M -355.925% $-104.67 $-7.223M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2024 $3.839M $7.914M $3.638M $4.277M
Q2-2024 $6.013M $9.965M $5.395M $4.57M
Q4-2023 $93.875K $8.84M $12.669M $-3.829M
Q2-2023 $713.338K $36.508M $14.859M $21.649M
Q4-2022 $492.485K $38.997M $12.097M $26.9M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2024 $-1.413M $-1.388M $-1.12M $351.308K $-2.19M $-2.143M
Q2-2024 $-2.683M $-2.592M $104.05K $8.638M $5.938M $-3.936M
Q4-2023 $-26.397M $-589.09K $26.824K $272.034K $-349.463K $-588.656K
Q2-2023 $-5.878M $-911.484K $-1.935K $1.215M $187.535K $-913.419K
Q4-2022 $-9.389M $-3.116M $13.275K $-503.689K $-4.147M $-3.163M

Five-Year Company Overview

Income Statement

Income Statement Akanda’s income statement reflects a company still in transition and not yet generating meaningful sales. Revenue has effectively been near zero for several years, so reported results are driven mostly by operating costs, financing, and one‑off items rather than a healthy underlying business. Losses have been recurring, even if the absolute amounts look small, and earnings per share have been heavily distorted by repeated share consolidations. Overall, the past few years show a pattern of a company spending more than it brings in, with no clear revenue base yet from either cannabis or telecom to absorb fixed costs.


Balance Sheet

Balance Sheet The balance sheet looks very thin. The company operates with only a small pool of assets and essentially no cash cushion, which limits flexibility and raises sensitivity to any setbacks. Debt levels are modest, but that is partly because there is not much equity either; book equity has hovered close to zero and was negative at one point, signaling prior capital erosion. Multiple reverse stock splits also suggest that Akanda has had to recapitalize and manage a shrinking equity base over time. In simple terms, the financial foundation is fragile, and there is little room for prolonged missteps.


Cash Flow

Cash Flow Cash flows underline the same story: the core business has not funded itself. Operating cash flow has been weak or negative, which means the company has tended to consume cash rather than generate it. Free cash flow has also been negative, even though investment spending has been very light, so the strain mainly comes from ongoing operating expenses without offsetting inflows. This pattern usually implies reliance on external capital — new equity or other financing — to keep the business moving while management works to build up the new telecom revenue stream and any remaining cannabis operations.


Competitive Edge

Competitive Edge Akanda’s competitive position is unusual because it straddles two very different sectors. In cannabis, its original edge in Europe has largely been unwound: the sale of its Portuguese cultivation asset significantly reduced its presence and weakened what had been a vertically integrated model. What remains is mainly UK distribution and an early‑stage Canadian cultivation asset, which together form a niche, not a dominant, position. In contrast, the new telecom infrastructure arm in Mexico could offer a more scalable opportunity. Being a preferred contractor on a large national network project is strategically valuable, but Akanda is still a small player in a market with established telecom infrastructure providers. Its competitive standing will depend heavily on its ability to win and execute additional tower and fiber contracts, manage regulatory and country risks, and scale without overextending financially.


Innovation and R&D

Innovation and R&D Innovation at Akanda is more strategic and infrastructure‑driven than traditional lab research. On the cannabis side, the company once focused on high‑grade medical cultivation and branded partnerships, but that innovation base has been scaled back with asset sales. What remains is more about licensing, distribution, and potential product development in Canada and the UK rather than heavy scientific R&D. On the telecom side, the innovation is in building and operating tower and fiber networks in under‑served regions of Mexico, and in positioning itself for future 5G deployment. The key “R&D” here is really infrastructure planning, network design, and developing relationships with carriers and government programs. Future value will depend on how well Akanda turns these plans into reliable, recurring cash flows rather than on breakthrough technology.


Summary

Akanda is a small, financially constrained company that has undergone a major identity shift—from international medical cannabis toward telecom infrastructure in Mexico. The historic financials show minimal revenue, recurring losses, and a fragile balance sheet, highlighted by multiple reverse splits and thin equity. Strategically, the company has traded its earlier European cannabis moat for a shot at building a new position in Mexican telecom towers and fiber, while maintaining smaller cannabis assets in the UK and Canada. This creates both opportunity and complexity: two unrelated businesses, each at an early or rebuilding stage, funded by limited resources. The central issues to watch are whether Akanda can convert its telecom contracts into stable, growing cash flows, strengthen its balance sheet, and decide how committed it remains to cannabis versus becoming primarily a telecom infrastructure company.